Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2026-01-11 @ 8:07 AM
Study NCT ID:
NCT02773459
Status:
COMPLETED
Last Update Posted:
2019-09-30
First Post:
2016-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer
Sponsor:
Seoul National University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04
Start Date Type:
None
Primary Completion Date:
2019-01-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-13
First Submit QC Date:
None
Study First Post Date:
2016-05-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-27
Last Update Post Date:
2019-09-30
Last Update Post Date Type:
ACTUAL